Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Alternext  >  Cellectis    ALCLS   FR0010425595

CELLECTIS

(ALCLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about CELLECTIS
03/11CELLECTIS : US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to C..
AQ
03/10CELLECTIS S A : US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted ..
BU
03/04CELLECTIS : Provides Business Update and Reports 4th Quarter and Full Year 2019 ..
BU
03/04CELLECTIS : and Servier Execute the Amendment Confirming the Expansion of Their ..
BU
02/25CELLECTIS TO HOLD FOURTH QUARTER AND : 30 am est
BU
02/19CELLECTIS : and Servier Expand Collaboration on UCART19 Products; Cellectis : gr..
AQ
02/18CELLECTIS : and Servier Expand Collaboration on UCART19 Products
BU
01/16CELLECTIS : First Patient Dosed with Cellectis' New Allogeneic UCART123 Product ..
AQ
01/15CELLECTIS S A : First Patient Dosed with Cellectis' New Allogeneic UCART123 Prod..
BU
01/07CELLECTIS : and World Experts Review New Avenue of Allogeneic CAR T-cells, Optim..
AQ
01/07CELLECTIS : An Expert Review on Allogeneic CAR-T for Cancer Published in Nature ..
AQ
01/07CELLECTIS : An Expert Review on Allogeneic CAR-T for Cancer Published in Nature ..
AQ
01/06CELLECTIS :  An Expert Review on Allogeneic CAR-T for Cancer Published in Nature..
BU
2019CELLECTIS : 1st Patient Dosed with Cellectis' Allogeneic UCART22 in Relapsed/Ref..
AQ
2019CELLECTIS S A : 1st Patient Dosed with Cellectis' Allogeneic UCART22 in Relapsed..
BU
More most relevant news
All news about CELLECTIS
03/26CALYXT, INC. : Financial Statements and Exhibits (form 8-K)
AQ
03/11CELLECTIS : US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to C..
AQ
03/10CELLECTIS S A : US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted ..
BU
03/05CALYXT, INC. : Results of Operations and Financial Condition, Regulation FD Disc..
AQ
03/04CELLECTIS : Provides Business Update and Reports 4th Quarter and Full Year 2019 ..
BU
03/04CELLECTIS : and Servier Execute the Amendment Confirming the Expansion of Their ..
BU
02/25CELLECTIS TO HOLD FOURTH QUARTER AND : 30 am est
BU
02/19CELLECTIS : and Servier Expand Collaboration on UCART19 Products; Cellectis : gr..
AQ
02/18CELLECTIS : and Servier Expand Collaboration on UCART19 Products
BU
02/05CALYXT, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
News in other languages on CELLECTIS
03/11EN DIRECT DES MARCHES : Renault, Sanofi, Air France, Boiron, Nicox, Adidas, F..
03/11STOCK MARKET PARIS : Déjà la rechute ?
03/11STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe
03/11STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe (actualisé)
03/10CELLECTIS : obtient un brevet aux États-Unis couvrant les cellules CAR-T allogén..
03/05EN DIRECT DES MARCHES : Airbus, Sanofi, ArcelorMittal, JCDecaux, Nicox, CNIM,..
03/05STOCK MARKET PARIS : Biden plus fort que le coronavirus
03/05BIOTECH TIME : Cellectis, Nicox, DBV Technologies, Pixium Vision
03/04CELLECTIS : publie ses résultats financiers du quatrième trimestre 2019 et de l'..
03/04CELLECTIS : et Servier signent un avenant confirmant l'expansion de leur collabo..
Press releases
03/26CALYXT, INC. : Financial Statements and Exhibits (form 8-K)
AQ
03/11CELLECTIS : US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to C..
AQ
03/10CELLECTIS S A : US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted ..
BU
03/05CALYXT, INC. : Results of Operations and Financial Condition, Regulation FD Disc..
AQ
03/04CELLECTIS : Provides Business Update and Reports 4th Quarter and Full Year 2019 ..
BU
More press releases
Upcoming event on CELLECTIS